SCM
IMVT icon

Soleus Capital Management’s Immunovant IMVT Stock Holding History

Soleus Capital Management’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.71M Sell
230,000
-880,000
-79% -$22.8M 0.23% 63
2025
Q4 		$28.2M Buy
+1,110,000
New +$24.8M 1.2% 25
2024
Q4 		– Sell
-9,678
Closed -$276K – 95
2024
Q3 		$276K Sell
9,678
-242,222
-96% -$7.14M 0.02% 86
2024
Q2 		$6.65M Sell
251,900
-12,750
-5% -$363K 0.59% 55
2024
Q1 		$8.55M Sell
264,650
-52,400
-17% -$1.91M 0.75% 49
2023
Q4 		$13.4M Sell
317,050
-82,549
-21% -$3.04M 1.48% 22
2023
Q3 		$15.3M Buy
399,599
+226,000
+130% +$5.11M 1.55% 25
2023
Q2 		$3.29M Buy
+173,599
New +$3.24M 0.37% 60

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return